
Comparative statistics by cancer registry
Table2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site
(Harare, Zimbabwe, 1993-1997 cases* followed-up until 1999, all races together)Click on cancer site (ICD-10 code) for comparison
Site | ICD-10 | No. of cases included | Complete FU | Incomplete FU: loss to FU | % with Complete FU at 5 years | Median FU (in months) | ||||||
Alive/dead | At end of FU | No. | % | % lost to FU: years from diagnosis | ||||||||
No. | % | <1 | 1-3 | 3-5 | >5 | |||||||
C15 | Oesophagus | 131 | 131 | 100.0 | 0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 2.3 |
C16 | Stomach | 129 | 127 | 98.4 | 2 | 1.6 | 1.6 | 0.0 | 0.0 | 0.0 | 98.4 | 4.8 |
C18 | Colon | 57 | 57 | 100.0 | 0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 14.6 |
C19-20 | Rectum | 67 | 65 | 97.0 | 2 | 3.0 | 1.5 | 1.5 | 0.0 | 0.0 | 97.0 | 16.1 |
C22 | Liver | 132 | 131 | 99.2 | 1 | 0.8 | 0.8 | 0.0 | 0.0 | 0.0 | 99.2 | 1.0 |
C32 | Larynx | 73 | 69 | 94.5 | 4 | 5.5 | 5.5 | 0.0 | 0.0 | 0.0 | 94.5 | 14.1 |
C33-34 | Lung | 116 | 116 | 100.0 | 0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 2.0 |
C43 | Melanoma skin | 101 | 100 | 99.0 | 1 | 1.0 | 1.0 | 0.0 | 0.0 | 0.0 | 99.0 | 54.2 |
C46 | Kaposi sarcoma | 151 | 151 | 100.0 | 0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 3.4 |
C50 | Breast | 258 | 250 | 96.9 | 8 | 3.1 | 2.7 | 0.4 | 0.0 | 0.0 | 96.9 | 39.3 |
C53 | Cervix | 264 | 260 | 98.5 | 4 | 1.5 | 1.1 | 0.4 | 0.0 | 0.0 | 98.5 | 26.2 |
C56 | Ovary | 63 | 63 | 100.0 | 0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 18.7 |
C61 | Prostate | 64 | 61 | 95.3 | 3 | 4.7 | 4.7 | 0.0 | 0.0 | 0.0 | 95.3 | 16.6 |
C67 | Urinary bladder | 130 | 127 | 97.7 | 3 | 2.3 | 1.5 | 0.8 | 0.0 | 0.0 | 97.7 | 11.8 |
C69 | Eye | 116 | 114 | 98.3 | 2 | 1.7 | 0.9 | 0.9 | 0.0 | 0.0 | 98.3 | 42.1 |
C81 | Hodgkin lymphoma | 39 | 39 | 100.0 | 0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 | 30.6 |
C82-85+C96 | Non-Hodgkin lymphoma | 99 | 97 | 98.0 | 2 | 2.0 | 2.0 | 0.0 | 0.0 | 0.0 | 98.0 | 7.8 |
Other tables available for this registry:
- Table1: | Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Harare, Zimbabwe, 1993-1997 cases* followed-up until 1999, all races together) |
- Table2a: | Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site (Harare, Zimbabwe, 1993-1997 cases* followed-up until 1999, all races together) |
- Table4: | Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Harare, Zimbabwe, all races, 1993-1997 cases* followed-up until 1999) |
Registry chapter:
![]() | Consult the chapter in Cancer survival in developping countries (Volume II) |